The healthcare sector is facing a decisive moment. While nursing shortages continue to dominate national conversations and ...

Q1 2026 Earnings Call Transcript January 8, 2026 Simulations Plus, Inc. misses on earnings expectations. Reported EPS is ...

CARE-ACE supports autonomy through bounded agentic reasoning, in which diagnostic, prognostic, planning, and risk-assessment ...

Harvard Medical School brings healthcare simulation programme to Indian school students providing insights of clinical scenarios: Our Bureau, Bengaluru Monday, December 29, 2025, ...

DeyLight announced the launch of a new 22-week virtual training program designed to strengthen nursing education ...

At Carleton University, researchers are addressing a growing demand for advanced systems that enable learners to practice ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported ...

Some students at the University of Iowa are getting hands-on medical experience before the spring semester officially begins ...

Q1 FY2026 earnings call recap: revenue $18.4M, guidance reaffirmed, services strength, AI rollout, mix outlook—read key insights.

Silo Pharma, Inc. (Nasdaq: SILO) ("Silo” or the "Company”), a diversified developmental stage biopharmaceutical and ...

Despite a dip in total revenue, Simulations Plus Inc (SLP) showcases resilience with robust services performance and ...

The drug development software and services provider reported adjusted earnings per share of $0.13 for the quarter ended November 30, 2025, missing the analyst estimate of $0.19 by $0.06. Revenue came ...